Key NAFLD/NASH Studies Influencing My Practice Following EASL 2019

EASL 2019 Program Image
April 10-14, 2019; Vienna, Austria
Listen as expert faculty discusses the clinical impact of the most important NAFLD/NASH data from the Vienna meeting.
Zobair Younossi Headshot
Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD
Format: Audio (.mp3)
File Size: 16.0 MB
Released: May 2, 2019

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by:
AbbVie
Gilead Sciences

Related Content

Theo Tiến sĩ Nancy Reau, chúng ta có thể biết các hướng dẫn thực hiện sàng lọc virus viêm gan D thông qua các biện pháp chăm sóc lâm sàng (CCO)

Nancy Reau, MD Released: January 26, 2023

Matuto mula kay Dr Nancy Reau kung bakit maaaring gusto naming hamunin ang mga kasalukuyang alituntunin sa pagsusuri ng HDV, mula sa Clinical Care Options (Mga Opsyon sa Klinikal na Pangangalaga) (CCO)

Nancy Reau, MD Released: January 26, 2023

从 Nancy Reau 博士那里了解我们为什么要挑战当前的 HDV 筛查指南,来自 Clinical Care Options (CCO)

Nancy Reau, MD Released: January 25, 2023

Learn from Dr Nancy Reau why we may want to challenge current guidelines on HDV screening, from Clinical Care Options (CCO)

Nancy Reau, MD Released: January 5, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings